Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Steinberger

Showing results (11-20 of 137) with videos related to

Pageof 14
Sort By:
Immunology Letters|June 25, 2008
Host antimicrobial proteins as endogenous immunomodulatorsMarkus A Hölzl, Johannes Hofer, Peter Steinberger, et al.
Cold Spring Harbor Protocols|September 2, 2011
Generation of human Fab antibody libraries: PCR amplification and assembly of light- and heavy-chain coding sequencesJennifer Andris-Widhopf, Peter Steinberger, Roberta Fuller, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 22, 2024
Inhibitory CARs fail to protect from immediate T cell cytotoxicityMaximilian A Funk, Gerwin Heller, Petra Waidhofer-Söllner, et al.
Biochemical Pharmacology|September 11, 2016
Downstream effect profiles discern different mechanisms of integrin αLβ2 inhibitionRiccardo V Mancuso, Karl Welzenbach, Peter Steinberger, et al.
Cold Spring Harbor Protocols|September 2, 2011
Generation of human scFv antibody libraries: PCR amplification and assembly of light- and heavy-chain coding sequencesJennifer Andris-Widhopf, Peter Steinberger, Roberta Fuller, et al.
Vaccines|July 27, 2024
SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local ImmunityJoshua Tobias, Peter Steinberger, Joy Wilkinson, et al.
Frontiers in Immunology|August 14, 2023
FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and VarlilumabJudith Leitner, Ricarda Egerer, Petra Waidhofer-Söllner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2015
CD58/CD2 Is the Primary Costimulatory Pathway in Human CD28-CD8+ T CellsJudith Leitner, Dietmar Herndler-Brandstetter, Gerhard J Zlabinger, et al.
Immunology Letters|July 16, 2011
The effects of Cyclosporine A and azathioprine on human T cells activated by different costimulatory signalsJudith Leitner, Karin Drobits, Winfried F Pickl, et al.
Scientific Reports|September 12, 2018
PD-1 has a unique capacity to inhibit allergen-specific human CD4<sup>+</sup> T cell responsesSandra Rosskopf, Beatrice Jahn-Schmid, Klaus Georg Schmetterer, et al.
Pageof 14

Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
Immunology Letters|June 25, 2008
Host antimicrobial proteins as endogenous immunomodulatorsMarkus A Hölzl, Johannes Hofer, Peter Steinberger, et al.
Cold Spring Harbor Protocols|September 2, 2011
Generation of human Fab antibody libraries: PCR amplification and assembly of light- and heavy-chain coding sequencesJennifer Andris-Widhopf, Peter Steinberger, Roberta Fuller, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 22, 2024
Inhibitory CARs fail to protect from immediate T cell cytotoxicityMaximilian A Funk, Gerwin Heller, Petra Waidhofer-Söllner, et al.
Biochemical Pharmacology|September 11, 2016
Downstream effect profiles discern different mechanisms of integrin αLβ2 inhibitionRiccardo V Mancuso, Karl Welzenbach, Peter Steinberger, et al.
Cold Spring Harbor Protocols|September 2, 2011
Generation of human scFv antibody libraries: PCR amplification and assembly of light- and heavy-chain coding sequencesJennifer Andris-Widhopf, Peter Steinberger, Roberta Fuller, et al.
Vaccines|July 27, 2024
SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local ImmunityJoshua Tobias, Peter Steinberger, Joy Wilkinson, et al.
Frontiers in Immunology|August 14, 2023
FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and VarlilumabJudith Leitner, Ricarda Egerer, Petra Waidhofer-Söllner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2015
CD58/CD2 Is the Primary Costimulatory Pathway in Human CD28-CD8+ T CellsJudith Leitner, Dietmar Herndler-Brandstetter, Gerhard J Zlabinger, et al.
Immunology Letters|July 16, 2011
The effects of Cyclosporine A and azathioprine on human T cells activated by different costimulatory signalsJudith Leitner, Karin Drobits, Winfried F Pickl, et al.
Scientific Reports|September 12, 2018
PD-1 has a unique capacity to inhibit allergen-specific human CD4<sup>+</sup> T cell responsesSandra Rosskopf, Beatrice Jahn-Schmid, Klaus Georg Schmetterer, et al.
Pageof 14